SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

NORRIS MEDICINES

BSE: 524414 29 Jun 2025
Services
₹ 18.8
Norris Medicines Ltd. specializes in Trading & Distributors within the Services sector.

NORRIS MEDICINES - Share Price & Details

Market Cap
₹18.0
High /Low
27.7 / 11.4
Stock P/E
NA
Book Value
₹-14.9
Dividend Yield
0.0
ROCE
-10.1
ROE
₹NA
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-198.0
Debt
21.6
CMP / FCF
31.6
Debt to equity
₹NA
NP Ann
-1.24
High price all time
36.8
Piotroski score
₹4.0
Graham Number
NA
No. Eq. Shares
1.0
Net CF
₹0.40
Net profit
-1.24
Price to book value
NA
Interest Coverage
₹-1.68
Low price all time
2.45
Industry PE
34.7
Reserves
₹-24.8
Free Cash Flow
₹0.28

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Alna Trading & Exports Ltd.,NANANANA0
Oseaspre Consultants Ltd.,NANANANA0
NORRIS MEDICINES LTD.NANANANA18.0
INTER STATE OIL CARRIER LTD.NANANANA1815.8
AA Plus Tradelink LimitedNANANANA1819.0

Peer Comparison Chart


About NORRIS MEDICINES

Norris Medicines Ltd., with Security Code 524414, is a leading player in the Trading & Distributors industry, categorized under the Services sector, offering Equity instruments.


Latest News

Norris Medicines Experiences Shift in Market Sentiment Amid Financial Challenges

(11 Jun 2025)
Norris Medicines, a microcap in the Trading & Distributors sector, has experienced a shift in its technical indicators, moving towards a...
Read more →

How has been the historical performance of the Norris Medicines?

(11 Jun 2025)
Norris Medicines has experienced a significant decline in net sales and profitability, with net sales dropping from Rs 16.27 crore in March 2019 to Rs 5.82...
Read more →

Norris Medicines Ltd Faces Increased Selling Pressure Amidst Consecutive Losses

(10 Jun 2025)
Norris Medicines Ltd is experiencing notable selling pressure, continuing a trend of losses with a 2.81% decline today. Despite a strong monthly performance...
Read more →

Norris Medicines Faces Mixed Technical Trends Amid Strong Yearly Performance and Fundamental Challenges

(05 Jun 2025)
Norris Medicines, a microcap in the Trading & Distributors sector, has experienced a recent evaluation adjustment reflecting shifts in...
Read more →

Norris Medicines Ltd Sees Strong Buying Activity Amid Notable Price Gains

(05 Jun 2025)
Norris Medicines Ltd is experiencing notable buying activity, with a significant increase in its stock price today, outperforming the Sensex...
Read more →

Norris Medicines Faces Intense Selling Pressure Amid Consecutive Losses and Market Shift

(04 Jun 2025)
Norris Medicines Ltd is experiencing notable selling pressure, marked by consecutive losses and a significant decline in stock value.
Read more →